Healthcare Industry News: BD
News Release - October 2, 2006
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose SystemsINDIANAPOLIS, Oct. 2 (HSMN NewsFeed) -- BD Logic blood glucose meter users can receive a free ACCU-CHEK blood glucose system (meter and strips) by calling 1-888-355-4242. Roche will be providing a starter kit which includes a coupon for a free ACCU-CHEKŪ blood glucose system, redeemable at a retailer of the users' choice. Last week, Becton, Dickinson announced that they would be exiting their blood glucose monitoring business. Roche Diagnostics made the announcement today in order to ensure that BD's consumers can continue to closely manage their disease through self-testing.
"BD has made valuable contributions to diabetes patient care and will continue to do so with their other diabetes products. We're here to help their consumers and healthcare professionals in any way that we can with our portfolio of ACCU-CHEK blood glucose systems," said Don Dumoulin, Senior Vice President, Diabetes Care, Roche Diagnostics.
ACCU-CHEK products are preferred on most health plans, and have wide retail and mail order distribution.
Two blood glucose systems are available through this offer -- the ACCU-CHEK Aviva and ACCU-CHEK Compact Plus systems. The ACCU-CHEK Aviva system has a wide mouth on the test strip which quickly pulls in the small blood sample and is designed to fill the very first time. It is packaged with the ACCU-CHEK Multiclix lancet device which has a patented, lancet drum with six preloaded lancets. The ACCU-CHEK Compact Plus system is an integrated system that provides the convenience of an all-in-one system. The system features a preloaded drum with 17 test strips, no coding(1) and the ACCU-CHEK Softclix Plus detachable lancet device for one-handed operation.
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology. In 2005 sales by the Pharmaceuticals Division totaled 27.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.2 billion Swiss francs. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Roche's Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories worldwide.
Roche Diagnostics North American headquarters is located in Indianapolis, Ind. (www.roche-diagnostics.us and www.accu-chek.com). For further information, please visit our Web sites www.roche.us and www.roche-diagnostics.com.
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for comprehensive diabetes management systems and services. For 30 years, the ACCU-CHEK brand has been committed to making life easier for people with diabetes and healthcare professionals with innovative products and services which make diabetes management more convenient, more efficient and cost effective. Today, the ACCU-CHEK brand is completing the circle of care in diabetes management by offering people with diabetes and healthcare professionals all they need spanning from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems
ACCU-CHEK, ACCU-CHEK COMPACT, ACCU-CHEK AVIVA, ACCU-CHEK MULTICLIX and SOFTCLIX are trademarks of Roche.
All other product names and trademarks are the property of their respective owners.
(1) User is not required to code the meter.
Source: Roche Diagnostics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.